Therapeutic Goods (Revocation of Notifiable Instrument Relating to Articles that are not Medical Devices) Order 2018
I, Tracey Duffy, a delegate of the Secretary of the Department of Health for the purposes of section 41BD of the Therapeutic Goods Act 1989 (the Act), make the following order under section 41BD(3) of the Act.
Dated 20 March 2018
(Signed by)
TRACEY DUFFY
Delegate of the Secretary of the Department of Health
1 Name
This instrument is the Therapeutic Goods (Revocation of Notifiable Instrument Relating to Articles that are not Medical Devices) Order 2018.
2 Commencement
This instrument is taken to have commenced on 19 August 2017.
3 Authority
This instrument is made under section 41BD(3) of the Therapeutic Goods Act 1989.
5 Schedules
Each instrument that is specified in a Schedule to this instrument is revoked as set out in the applicable items in the Schedule concerned.
Schedule 1—Revocation of instruments
Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017
1 The whole of the instrument
Revoke the instrument.
Overview
The Therapeutic Goods (Revocation of Notifiable Instrument Relating to Articles that are not Medical Devices) Order 2018 was enacted to address the need for streamlining regulations surrounding therapeutic goods that do not fall under the category of medical devices. This order, made under section 41BD(3) of the Therapeutic Goods Act 1989, revokes the Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017, thereby removing certain regulatory burdens associated with these goods. The order was issued by Tracey Duffy, a delegate of the Secretary of the Department of Health, on 20 March 2018, with an effective commencement date of 19 August 2017. The primary objective of this legislative instrument is to enhance the efficiency of the regulatory framework for therapeutic goods that do not qualify as medical devices, aiming to facilitate better oversight and compliance within the sector.
Scope and Application
The Therapeutic Goods (Revocation of Notifiable Instrument Relating to Articles that are not Medical Devices) Order 2018 applies to the revocation of specific notifiable instruments under the Therapeutic Goods Act 1989, which governs the regulation of therapeutic goods in Australia. This revocation order specifically targets the Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017, and it is made by Tracey Duffy, a delegate of the Secretary of the Department of Health, pursuant to section 41BD(3) of the Act. The order is effective from 19 August 2017 and pertains to the national regulation of therapeutic goods, impacting entities and individuals involved in the manufacture, supply, or importation of therapeutic goods that are not classified as medical devices. The order revokes the previously established notifiable instruments concerning these goods, thereby altering the regulatory landscape for their oversight and compliance within Australia.
Key Provisions
The Therapeutic Goods (Revocation of Notifiable Instrument Relating to Articles that are not Medical Devices) Order 2018 (paragraph 1) revokes the Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017. This order, which came into effect on 19 August 2017 (paragraph 2), was made under section 41BD(3) of the Therapeutic Goods Act 1989 (paragraph 3). The specific instruments revoked are detailed in Schedule 1 of the 2018 Order. The revocation effectively removes the previous regulations concerning articles that are not classified as medical devices.
Entities and individuals subject to the Therapeutic Goods Act 1989 are required to comply with this revocation, which impacts the regulatory framework governing articles that are not classified as medical devices. This includes manufacturers, importers, and suppliers of such items. They must now operate under the general provisions of the Act without the specific requirements previously outlined in the revoked order. Compliance involves ensuring that their products and processes align with the overarching regulatory standards set out in the Act.
The Therapeutic Goods Act 1989 includes provisions for offences and penalties for non-compliance. While the revocation itself does not introduce new offences, it is important to note that continued operation under non-compliant regulations could result in enforcement actions. The maximum penalties for breaches of the Act can include substantial fines and, in serious cases, imprisonment. For instance, offences related to misleading or false representations can incur fines up to $222,000 for individuals and $1,110,000 for bodies corporate, alongside potential imprisonment terms. It is imperative that all entities ensure their operations remain in full compliance with the current legislative requirements.